Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| IMMUNITYBIO | 5 | 3 | +0,95 % | ||
| AMGEN | 4 | 27 | -0,79 % | ||
| GILEAD SCIENCES | 4 | 5 | -0,66 % | ||
| PROTHENA | 4 | 1 | 0,00 % | ||
| BIOCRYST PHARMACEUTICALS | 4 | - | -2,79 % | ||
| ALECTOR | 4 | - | 0,00 % | ||
| CYTOKINETICS | 3 | 1 | -3,70 % | ||
| MINERALYS THERAPEUTICS | 3 | 1 | +2,33 % | ||
| BIONTECH | 2 | 13 | +0,06 % | ||
| AVADEL PHARMACEUTICALS | 2 | 6 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:26 | ImmunityBio (IBRX) Climbs 7.76% on Europe Expansion | 1 | Insider Monkey | ||
| 13:54 | Lululemon, Biogen to exit Nasdaq 100 with Alnylam, Seagate among additions | 4 | Seeking Alpha | ||
| 06:45 | Neural Therapeutics mit Partner Hanf.com, MindMed und Tilray: Neue Chancen durch strengere Regeln im Cannabismarkt | Small- & Micro Cap Investment | |||
| 04:59 | FDA Approves Innoviva's NUZOLVENCE, First-in-Class Oral Treatment For Gonorrhea | 5 | RTTNews | ||
| 01:06 | Amgen CDR (CAD Hedged): Amgen CDR (CAD Hedged) declares dividend | 7 | Stockwatch | ||
| Fr | Alector Names Neil Berkley As Chief Financial Officer | 1 | RTTNews | ||
| Fr | Prothena Announces Board of Directors Update | 1 | City A.M. | ||
| Fr | Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Fr | GSK beendet Partnerschaft: Ideaya Biosciences erhält Rechte für zwei Programme zurück | 2 | Investing.com Deutsch | ||
| Fr | Alector appoints Neil Berkley as chief financial officer | 1 | Seeking Alpha | ||
| Fr | Artiva Biotherapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Fr | Paula Cobb steps down from Prothena's board to join Manifold Bio | 1 | Investing.com | ||
| Fr | Anavex Life Sciences Corp.: Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease | 41 | GlobeNewswire (Europe) | NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments... ► Artikel lesen | |
| Fr | Alector, Inc.: Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer | 50 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression... ► Artikel lesen | |
| Fr | 4D Molecular Therapeutics, Inc.: 4DMT Announces New Employment Inducement Grants | 1 | GlobeNewswire (USA) | ||
| Fr | FDA endorses 2nd new gonorrhea treatment, clearing way for Innoviva's Nuzolvence | 2 | FiercePharma | ||
| Fr | Prothena Corporation plc: Prothena Announces Board of Directors Update | 216 | Business Wire | Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced... ► Artikel lesen | |
| Fr | $100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today | 1 | Benzinga.com | ||
| Fr | Ascendis Pharma gains amid takeover speculation | 1 | Seeking Alpha | ||
| Fr | PROTHENA CORP PUBLIC LTD CO - 8-K, Current Report | - | SEC Filings |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .